Status:
RECRUITING
iCBT for GD and Comorbidities - a Pilot
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Deakin University
Conditions:
Gambling Disorder
Comorbidities and Coexisting Conditions
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is a pilot study (Total N=30), with at pre, weekly during treatment, post and at three-month follow-up.
Detailed Description
Recruitment will be done through online advertisement via social media and gambling-related websites. Participants will self-referred to the study via a study dedicated website (www.spelstudien.se). L...
Eligibility Criteria
Inclusion
- Screen positive for GD, as measured with the Gambling Disorder Identification Test (total score ≥20 GDIT).
- Fulfilling GD, assessed according to the Structured Clinical Interview for Gambling Disorder (SCI-GD).
- Utilization of "Spelpaus" (3 months from treatment start).
- ≥18 years of age.
- Able to provide digital informed consent.
- Classified within pathways 2 or 3, as measured with the Gambling pathways Questionnaire (GPQ).
- Screen positive for at least one common mental diagnosis in addition to GD, assessed according to the Web Screening Questionnaire (WSQ).
Exclusion
- Other ongoing psychological treatment for GD.
- Severe depression, screened according to the Montgomery Åsberg Depression Rating Scale (total score \>34 MADRS-S).
- Suicidality, screening of ≥4 points on item 9 of the MADRS-S
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06107621
Start Date
December 1 2023
End Date
June 1 2024
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for psychiatry research
Stockholm, Sweden, 116 30